These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34779003)

  • 21. Population pharmacokinetics of cyclosporine A in hematopoietic stem cell transplant recipients: A systematic review.
    Yang Y; Zhu Y; Xia L; Chai Y; Quan D; Xue Q; Wang Z
    Eur J Pharm Sci; 2025 Jan; 204():106882. PubMed ID: 39214318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing cyclosporine A dose post allogeneic hematopoietic stem cell transplantation in paediatric cancer patients.
    Elnaggar M; Hafez H; Abdallah A; Hamza M; Khalaf MM; El-Haddad A
    J Oncol Pharm Pract; 2024 Sep; 30(6):983-991. PubMed ID: 37528663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of converting from intravenous to oral administration of cyclosporin A in pediatric allogeneic hematopoietic stem cell transplant recipients.
    Choi JS; Lee SH; Chung SJ; Yoo KH; Sung KW; Koo HH
    Bone Marrow Transplant; 2006 Jul; 38(1):29-35. PubMed ID: 16715103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation Decreases Ciclosporin Metabolism in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Malnoë D; Bories M; Pierre-Jean M; Marchand T; Le Corre P
    J Clin Pharmacol; 2024 Oct; ():. PubMed ID: 39382849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of a Population Pharmacokinetic Model to Improve a Busulfan Test-Dose Strategy in Allogeneic Hematopoietic Cell Transplant Recipients.
    Dunlap TC; Weiner DL; Kemper RM; Kardouh M; DeVane SC; Symonds A; Shaw JR; Armistead PM; Ptachcinski JR; Crona DJ
    J Clin Pharmacol; 2023 Sep; 63(9):1026-1035. PubMed ID: 37122163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.
    Kimura S; Oshima K; Okuda S; Sato K; Sato M; Terasako K; Nakasone H; Kako S; Yamazaki R; Tanaka Y; Tanihara A; Higuchi T; Nishida J; Kanda Y
    Bone Marrow Transplant; 2010 Jun; 45(6):1088-94. PubMed ID: 19898510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients.
    Saint-Marcoux F; Marquet P; Jacqz-Aigrain E; Bernard N; Thiry P; Le Meur Y; Rousseau A
    Clin Pharmacokinet; 2006; 45(9):905-22. PubMed ID: 16928152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter-Based Population Pharmacokinetic Analysis of Ciclosporin in Hematopoietic Stem Cell Transplantation Patients.
    Xue L; Zhang WJ; Tian JX; Liu LN; Yan HH; Zhang WW; Ding XL; Zhang JJ; Miao LY
    Pharm Res; 2019 Dec; 37(1):15. PubMed ID: 31873806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
    Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of cyclosporine-A concentration in T-cell replete haploidentical allogeneic stem cell transplantation.
    Yang X; Yang S; Sun A; Qiu H; Tang X; Han Y; Wu D
    Clin Transplant; 2018 Apr; 32(4):e13220. PubMed ID: 29493007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of posaconazole on the concentration of intravenous and oral cyclosporine in patients undergoing hematopoietic stem cell transplantation.
    Zhu LE; Huang HP; Cai YP; Wang Y; Xu BH; Liu MB; Wu XM
    Eur J Clin Pharmacol; 2022 Oct; 78(10):1677-1685. PubMed ID: 36045212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics of mycophenolic acid in renal transplant recipients.
    van Hest RM; van Gelder T; Vulto AG; Mathot RA
    Clin Pharmacokinet; 2005; 44(10):1083-96. PubMed ID: 16176120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine levels > 195 μg/L on day 10 post-transplant was associated with significantly reduced acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Bianchi M; Heim D; Lengerke C; Halter J; Gerull S; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
    Ann Hematol; 2019 Apr; 98(4):971-977. PubMed ID: 30542943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetics of cyclosporine in cardiopulmonary transplant recipients.
    Rosenbaum SE; Baheti G; Trull AK; Akhlaghi F
    Ther Drug Monit; 2005 Apr; 27(2):116-22. PubMed ID: 15795639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of pretransplantation cyclosporine pharmacokinetic studies on initial post-transplantation dosing in pediatric kidney allograft recipients.
    Seikku P; Hoppu K; Jalanko H; Holmberg C
    Pediatr Transplant; 2003 Apr; 7(2):102-10. PubMed ID: 12654050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetics of sirolimus in Chinese adult liver transplant recipients: a retrospective study.
    Zhang Y; Zhang X; Zou Y; Sun Y; Li X
    Xenobiotica; 2021 Dec; 51(12):1408-1415. PubMed ID: 34983304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of a Bayesian Individualization of Cyclosporine Dosage Regimen for Children Undergoing Allogeneic Hematopoietic Cell Transplantation: A Cost-Effectiveness Analysis.
    Beyron C; Ceraulo A; Bertrand Y; Bleyzac N; Philippe M
    Ther Drug Monit; 2021 Aug; 43(4):481-489. PubMed ID: 33814541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics of ciclosporin in Chinese children with aplastic anemia: effects of weight, renal function and stanozolol administration.
    Ni SQ; Zhao W; Wang J; Zeng S; Chen SQ; Jacqz-Aigrain E; Zhao ZY
    Acta Pharmacol Sin; 2013 Jul; 34(7):969-75. PubMed ID: 23624757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients.
    de Winter BC; Monchaud C; Prémaud A; Pison C; Kessler R; Reynaud-Gaubert M; Dromer C; Stern M; Guillemain R; Knoop C; Estenne M; Marquet P; Rousseau A
    Clin Pharmacokinet; 2012 Jan; 51(1):29-39. PubMed ID: 22054177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occurrence and influencing factors of cyclosporine A on the kidney injury following allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
    Lu R; Shi Y; Yang M; Yang N; He S; Xin L; Qin Y; Li H; Zeng L; Zou K; Yang C; Huang L; Shi W; Qiu X; Lu X; Zhang L
    Int Immunopharmacol; 2023 Sep; 122():110633. PubMed ID: 37451015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.